与此同时，在由上海证券报·中国证券网主办的2025"上证鹰·金质量"评选活动中，雅本化学再获"科技创新奖"。该奖项聚焦企业在技术研发、产品创新及产 业升级方面的突出贡献，雅本化学凭借其在研发能力建设、工艺技术改进及绿色化学实践等领域的持续投入与突破，赢得了评委的一致认可。 近年来，雅本化学坚持"创新驱动+绿色可持续"双轮驱动赋能创新医药、创新农药双主业发展，持续加大研发投入，推动核心产品技术升级，同时积极构建 完善的ESG管理体系，提升企业综合竞争力。此次连获两项大奖，不仅是对公司过往成绩的肯定，更为其未来高质量发展注入强劲动力。 2025年12月，在资本市场持续强化高质量发展导向的背景下，雅本化学（300261）（300261.SZ）凭借其在科技创新与环境、社会及治理（ESG）领域的突 出表现，连续获得两项主流证券媒体权威奖项，进一步巩固其在行业中的领先地位。 在"第十九届上市公司价值评选"中，雅本化学荣获"上市公司ESG百强"奖项，公司董事长蔡彤先生亦被授予"中国上市公司年度ESG先锋人物"称号。该评选 由证券时报主办，旨在表彰在可持续发展、社会责任和公司治理方面表现卓越的上市公司。雅本化学此次获奖，充分 ...

据不完全统计，近年来，豪威集团、概伦电子、华熙生物等多家上市公司的实控人或控股股东均有类似 举措，捐赠用途多集中于支持母校学科建设、人才培养及科研发展。此次蔡彤捐赠设立的"复旦创业人 股票基金"，聚焦于创业教育领域的支持，与当前鼓励创新创业的社会导向相契合。上海复旦大学教育 发展基金会作为受赠方，其独立的公益性组织属性，也确保了捐赠资金将按照协议约定专项用于创业相 关的教育事业。 今年前三季度，雅本化学实现营业收入9.96亿元，同比增长6.00%；归母净利润-691.64万元。该公司表 示，过去两年行业景气度低迷，客户普遍处于去库存阶段。然而，中国作为全球农化中间体主要生产国 的地位并未动摇，当前市场需求正逐步改善。随着客户库存调整趋于尾声，叠加创新产品需求陆续落 地，行业景气度有望企稳。 雅本化学表示，展望四季度，公司目前以CDMO业务为主，四季度各项业务正有序推进。随着近年来创 新中间体、原药的客户需求逐步释放，主业经营状况进入改善通道。 12月4日晚，雅本化学（300261）发布公告称，公司实际控制人蔡彤于12月3日签署捐赠协议，向上海复 旦大学教育发展基金会无偿捐赠135.8696万股公司股份，以当前 ...

格隆汇12月4日｜雅本化学(300261.SZ)公告称，公司实际控制人蔡彤于2025年12月3日签署《复旦创业 人股票基金捐赠协议》，向上海复旦大学教育发展基金会无偿捐赠135.8696万股公司股份，市值约人民 币1,000万元，用于设立"复旦创业人股票基金"。本次捐赠的公司股份均为无限售流通股。本次捐赠完 成后，蔡彤、汪新芽合计控制的公司股份将减少至35.89%。 ...

格隆汇12月4日丨雅本化学(300261.SZ)公布，为积极履行企业家社会责任，支持母校复旦大学相关事业 发展，并助力其创业文化的培育与拓展，公司实际控制人蔡彤先生于2025年12月3日签署《复旦创业人 股票基金捐赠协议》，向上海复旦大学教育发展基金会无偿捐赠135.8696万股公司股份，市值约人民币 1,000万元，用于设立"复旦创业人股票基金"。本次捐赠的股份后续将通过非交易过户的方式在中国证 券登记结算有限公司深圳分公司办理过户登记手续。蔡彤先生本次捐赠的公司股份均为无限售流通股。 ...

证券代码：300261 证券简称：雅本化学 公告编号：2025-080 雅本化学股份有限公司 关于实际控制人无偿捐赠股份暨持股比例变动 触及 1%整数倍的公告 股东蔡彤先生及一致行动人保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 为积极履行企业家社会责任，支持母校复旦大学相关事业发展，并助力其创 业文化的培育与拓展，公司实际控制人蔡彤先生于 2025 年 12 月 3 日签署《复旦 创业人股票基金捐赠协议》，向上海复旦大学教育发展基金会无偿捐赠 135.8696 万股公司股份，市值约人民币 1,000 万元，用于设立"复旦创业人股票基金"。 本次捐赠的股份后续将通过非交易过户的方式在中国证券登记结算有限公司深 圳分公司办理过户登记手续。蔡彤先生本次捐赠的公司股份均为无限售流通股。 二、受赠方基本情况 名称：上海复旦大学教育发展基金会 统一社会信用代码：53310000501779147H 性质：非公募基金会，属慈善组织 成立时间：2004 年 6 月 1 日 法定代表人：许征 业 ...

雅本化学股份有限公司 关于召开2025年第四次临时股东会通知的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 根据雅本化学股份有限公司（以下简称"公司"）第六届董事会第七次会议 的决定，公司将于 2025 年 12 月 19 日召开公司 2025 年第四次临时股东会，现将 有关事项通知如下： 一、本次会议的基本情况 1、股东会届次：2025 年第四次临时股东会 2、股东会召集人：公司董事会 3、会议召开的合法、合规性：经公司第六届董事会第七次会议审议通过， 决定召开 2025 年第四次临时股东会，召集程序符合有关法律、行政法规、部门 规章、规范性文件和《公司章程》的规定。 证券代码：300261 证券简称：雅本化学 公告编号：2025-079 4、会议召开的日期、时间 现场会议时间：2025 年 12 月 19 日（星期五）下午 14:30 网络投票时间：2025 年 12 月 19 日 通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 12 月 19 日上 午 9:15-9:25，9:30-11:30 和下午 13:00-15:00； 通过深圳 ...

Core Insights - Yabao Chemical has been recognized as a "2025 Excellent Practice Case for Sustainable Development" by the China Association of Listed Companies, highlighting its achievements in sustainable development and innovation transformation [1] - The company's deep engagement in innovative pharmaceuticals and its green low-carbon transition are becoming key drivers for enhancing its competitiveness [1] Group 1: Sustainable Development Initiatives - Yabao Chemical was one of the first companies in China to implement the DuPont Sustainable Development Program in 2019, investing over 10 million yuan and training more than 100 management personnel [3] - In November 2023, the company committed to the Science Based Targets initiative (SBTi) as one of the first participants in its industry, with a long-term carbon reduction plan set to be officially reviewed by SBTi by June 2025 [3] Group 2: Strategic Focus on Green Technology - The chairman of Yabao Chemical emphasized that sustainable development is at the core of the company's strategy, and it aims to enhance competitiveness through green transformation [5] - The company is advancing green technology research and application in the innovative pharmaceutical sector, focusing on biosynthesis technology to replace traditional chemical synthesis processes, significantly improving the atomic economy of drug synthesis [5] Group 3: Emission Reduction Goals - To meet its SBTi commitment, Yabao Chemical aims to reduce Scope 1 and Scope 2 emissions by 54.9% and Scope 3 emission intensity by 61.1% by 2033, using 2022 as the baseline [6] - The company has implemented systematic emission reduction measures, achieving a 7.6% reduction in total Scope 1 and Scope 2 emissions compared to its target value for 2024 [6] Group 4: Competitive Advantage through Innovation - By integrating scientific carbon goals with innovative pharmaceutical development, Yabao Chemical is building a unique market competitive advantage [6] - Continuous investment in green technology is transforming costs into competitiveness, aligning with global low-carbon development trends and providing new momentum for long-term growth in the innovative pharmaceutical sector [6]

Core Perspective - The article discusses how companies can transform ESG investments from a compliance cost into a core capital that attracts investment, drives innovation, and builds competitive advantages, ultimately reshaping corporate value [1]. Value Transformation - Companies need to establish a quantifiable ESG assessment system to clearly present the relationship between input and output, avoiding the mindset of only calculating costs without considering value [2]. - ESG investments should be viewed as both costs and benefits, with potential for cost reduction and efficiency gains, such as installing solar panels, and attracting new investors through green financing [2]. - Long-term institutional investors are likely to increase as ESG practices improve, optimizing shareholder structure [2]. - ESG can drive business and product innovation, creating new growth points, especially for products with a lower carbon footprint [2]. Active Practice - The chemical industry is undergoing a green transformation, with companies like Changhua Chemical innovating through catalyst technology to utilize CO2 as a raw material, achieving significant production milestones [3]. - Yabao Chemical has invested over 10 million in sustainable development, responding to industry compliance and enhancing operational efficiency, becoming one of the early adopters of ESG reporting among private enterprises [3][4]. - Ctrip is addressing carbon emission challenges in the travel industry by integrating carbon data from airlines and establishing low-carbon standards for hotels, aligning with the preferences of environmentally conscious consumers [4]. Digital Empowerment - The integration of AI and ESG is becoming a key driver for sustainable development, with companies like Longxin Group leveraging technology to facilitate industry-wide transitions [5][6]. - Longxin Group has developed a distributed photovoltaic management platform covering 50GW of resources and a charging platform with 26 million registered users, significantly enhancing operational efficiency and reducing costs for businesses [6].

Core Viewpoint - The company has confirmed that it is selling dietary supplements, including NMN, through cross-border e-commerce platforms like Pinduoduo, and that these products are produced by qualified overseas manufacturers [2]. Group 1 - The company has engaged in the sale of various dietary supplements, including NMN, through multiple cross-border e-commerce channels [2]. - The sales operations are managed by the company's subsidiary, Hong Kong Yaben, and Abino, which are responsible for organizing the business [2]. - The production of these products is entrusted to qualified overseas manufacturers, ensuring compliance and quality [2].

Core Insights - Yabao Chemical has launched two innovative drug projects at its Yancheng and Lanzhou bases, with production lines completed and customer orders gradually being received starting this year [2] Group 1 - The company is actively seeking to engage with clients to explore more collaboration opportunities for innovative drug projects [2]